Fertility and apparent genetic anticipation in Lynch syndrome

被引:2
|
作者
Stupart, Douglas [1 ]
Win, Aung Ko [2 ]
Jenkins, Mark [2 ]
Winship, Ingrid M. [3 ]
Goldberg, Paul [4 ]
Ramesar, Rajkumar [5 ]
机构
[1] Deakin Univ, Dept Surg, Geelong Hosp, Ryrie St, Geelong, Vic 3227, Australia
[2] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Parkville, Vic 3052, Australia
[3] Royal Melbourne Hosp, Genet Med & Family Canc Clin, Parkville, Vic 3050, Australia
[4] Univ Cape Town, Dept Surg, Colorectal Unit, ZA-7925 Cape Town, South Africa
[5] Univ Cape Town, Inst Infect Dis & Mol Med, Div Human Genet, MRC Human Genet Res Unit, ZA-7925 Cape Town, South Africa
关键词
Lynch syndrome; Genetic anticipation; Fertility; COLORECTAL-CANCER; DISEASE; FAMILY; AGE;
D O I
10.1007/s10689-014-9714-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Genetic anticipation is the phenomenon in which age of onset of an inherited disorder decreases in successive generations. Inconsistent evidence suggests that this occurs in Lynch syndrome. A possible cause for apparent anticipation is fecundity bias, which occurs if the disease adversely affects fertility. The purpose of this study was to determine the effect of age of diagnosis of colorectal cancer (CRC) on lifetime fertility in Lynch syndrome, and whether this can falsely create the appearance of genetic anticipation. A computer model simulated age of diagnosis of CRC in hypothetical Lynch syndrome carriers and their offspring. The model assumed similar age distribution of CRC across generations (i.e. that there was no true anticipation). Age distribution of CRC diagnosis, and lifetime fertility rates (grouped by age of diagnosis of CRC) were determined from the Australasian Colorectal Cancer Family Registry (ACCFR). Apparent anticipation was calculated by comparing ages of diagnosis of CRC in affected parent-child pairs. A total of 1,088 patients with CRC were identified from the ACCFR. Total lifetime (cohort) fertility was related to age of diagnosis of CRC (correlation coefficient 0.13, P = 0.0001). In the simulation, apparent anticipation was 1.8 +/- A 0.54 years (P = 0.0044). Observed apparent anticipation in the ACCFR cohort was 4.8 +/- A 1.73 years (P = 0.0064). There was no difference in apparent anticipation between the simulate d and observed parent-child pairs (P = 0.89). The appearance of genetic anticipation in Lynch syndrome can be falsely created due to changes in fertility.
引用
收藏
页码:369 / 374
页数:6
相关论文
共 50 条
  • [41] Correction: The genetic landscape of Lynch syndrome in the Israeli population
    Aasem Abu Shtaya
    Sofia Naftaly Nathan
    Inbal Kedar
    Eitan Friedman
    Elizabeth Half
    Gabi Lidzbarsky
    Gili Reznick Levi
    Ido Laish
    Lior Katz
    Lily Bazak
    Lilach Peled Peretz
    Lina Basel Salmon
    Liza Douiev
    Marina Lifshitc Kalis
    Menachem Schechter
    Michal Barzily-Rokni
    Nadra Nasser Samra
    Naim Abu-Freha
    Ofir Hagari-Bechar
    Ori Segol
    Samar Mattar
    Sarit Farage Barhom
    Shikma Mordechai
    Shiri Shkedi Rafid
    Stavit A. Shalev
    Tamar Peretz-Yablonski
    Zohar Levi
    Revital Bruchim
    Chana Vinkler
    Rinat Bernstein-Molho
    Sari Lieberman
    Yael Goldberg
    Familial Cancer, 24 (2)
  • [42] The neglected role of preimplantation genetic testing for Lynch syndrome
    Dallagiovanna, Chiara
    Filippi, Francesca
    Riccaboni, Alessandra
    Vigano', Paola
    Martinelli, Fabio
    Somigliana, Edgardo
    Ricci, Maria Teresa
    Vitellaro, Marco
    REPRODUCTIVE BIOMEDICINE ONLINE, 2023, 46 (03) : 421 - 423
  • [43] Genetic modifiers of cancer risk in Lynch syndrome: a review
    Bente A. Talseth-Palmer
    Juul T. Wijnen
    Desma M. Grice
    Rodney J. Scott
    Familial Cancer, 2013, 12 : 207 - 216
  • [44] Who Should Have Genetic Testing for the Lynch Syndrome?
    Burt, Randall W.
    ANNALS OF INTERNAL MEDICINE, 2011, 155 (02) : 127 - +
  • [45] Guidelines on Genetic Evaluation and Management of Lynch Syndrome Response
    Giardiello, Francis M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 (01): : 193 - 193
  • [46] Risk Assessment, Genetic Testing, and Management of Lynch Syndrome
    Grover, Shilpa
    Syngal, Sapna
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2010, 8 (01): : 98 - 105
  • [47] Progress in genetic testing, classification, and identification of Lynch syndrome
    Vasen, HFA
    Boland, CR
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (16): : 2028 - 2030
  • [48] Genetic testing for Lynch syndrome: family communication and motivation
    Leenen, Celine H. M.
    den Heijer, Mariska
    van der Meer, Conny
    Kuipers, Ernst J.
    van Leerdam, Monique E.
    Wagner, Anja
    FAMILIAL CANCER, 2016, 15 (01) : 63 - 73
  • [49] Genetic modifiers of cancer risk in Lynch syndrome: a review
    Talseth-Palmer, Bente A.
    Wijnen, Juul T.
    Grice, Desma M.
    Scott, Rodney J.
    FAMILIAL CANCER, 2013, 12 (02) : 207 - 216
  • [50] Guidelines on genetic evaluation and management of Lynch syndrome Response
    Giardiello, Francis M.
    GASTROINTESTINAL ENDOSCOPY, 2015, 81 (01) : 244 - 244